Medicine
Nilotinib 150 mg capsule
Nilotinib 150 mg capsule is a generic prescription medicine for oral use, made by 7 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Nilotinib 50 mg capsules are supplied in bottles and nilotinib 150 mg and 200…
Key facts
- Active ingredient (INN)
- Nilotinib
- Brand
- Sold under the generic name
- Strength
- 150 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 4 blister pack, 4 cartons, 8 blister pack and 8 more
- Manufacturers
- CiplaIndiaNovadoz PharmaceuticalsIndiaTorrent PharmaceuticalsIndiaCamber PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaAvKAREApotex
- Origin register
- US FDA, United States
- Storage
- Nilotinib 50 mg capsules are supplied in bottles and nilotinib 150 mg and 200 mg capsules are supplied in blister packs. 150 mg Carton of 4 blister packs of (4x28).......................NDC 73190-033-12 Blisters of 28 capsules................................NDC 73190-033-11 200 mg Carton of 4 blister packs of (4x28).......................NDC 73190-034-12 Blisters of 28…
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01EA03 Nilotinib
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 May 2025
- Identifiers
- RxCUI 746606, 997653, 2715459 +3DailyMed set ID 4c0bc799-ce6a-822a-e063-6394a90ab748, 86dc5507-ae0a-43d2-8d5e-5b0568ce9c5e, e27c3e09-bc4f-4f01-be05-1c43ac72285d +4NDC 73190-033, 31722-779, 69097-031 +4Application ANDA218544, ANDA209651, NDA218922 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 4 blister pack in 1 carton / 28 capsule in 1 blister pack | 31722-779-33 | Camber PharmaceuticalsIndia | 19 November 2025 |
| 4 carton in 1 carton / 4 blister pack in 1 carton / 7 capsule in 1 blister pack | 69097-031-74 | CiplaIndia | 18 June 2025 |
| 4 carton in 1 carton / 2 blister pack in 1 carton / 14 capsule in 1 blister pack | 69097-031-91 | CiplaIndia | 18 June 2025 |
| 8 blister pack in 1 carton / 14 capsule in 1 blister pack | 43598-455-46 | Dr. Reddy's LaboratoriesIndia | 19 November 2025 |
| 28 capsule in 1 blister pack | 72205-238-63 | Novadoz PharmaceuticalsIndia | 20 November 2025 |
| 4 blister pack in 1 carton / 28 capsule in 1 blister pack | 72205-238-64 | Novadoz PharmaceuticalsIndia | 20 November 2025 |
| 4 blister pack in 1 carton / 28 capsule in 1 blister pack | 13668-710-57 | Torrent PharmaceuticalsIndia | 16 December 2025 |
| 1 blister pack in 1 carton / 28 capsule in 1 blister pack | 13668-710-91 | Torrent PharmaceuticalsIndia | 16 December 2025 |
| 4 carton in 1 carton / 2 blister pack in 1 carton / 14 capsule in 1 blister pack | 60505-3801-2 | Apotex | 23 May 2025 |
| 28 capsule in 1 blister pack | 73190-033-11 | AvKARE | 2 March 2026 |
| 4 blister pack in 1 carton / 28 capsule in 1 blister pack | 73190-033-12 | AvKARE | 2 March 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Nilotinib 150 mg capsule.
Other strengths and forms of Nilotinib
Clinical summary
Nilotinib is a kinase inhibitor indicated for the treatment of adult and pediatric patients greater than or equal to 1 year of age with newly diagnosed Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase. MedsAcross supplies Nilotinib for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about NilotinibFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Tasigna prescribing information (Novartis Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Tasigna: European public assessment report (EPAR) · European Medicines Agency
- Nilotinib Accord: European public assessment report (EPAR) · European Medicines Agency
Need Nilotinib 150 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.